The case for MDMA’s approval is riddled with problems
10 min
What happens when psychedelic medicine gets rid of the "therapy" part of the treatment? In 2024, the first results of a unique LSD for anxiety trial are purporting to do just that. Rich Haridy examines what this means for the future of psychedelic medicine. Read by Sean Crisden.